A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada

This study models the impact of using two different types of high-risk (HR) human papillomavirus (HPV) tests: mRNA (Aptima) and DNA (Hybrid Capture 2) as part of a hypothetical primary HPV screening program in Ontario, Canada. Outcomes were the costs of the screening program, and number of colposcop...

Descripción completa

Detalles Bibliográficos
Autores principales: Weston, Georgie, Dombrowski, Caroline, Steben, Marc, Popadiuk, Catherine, Bentley, James, Adams, Elisabeth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334715/
https://www.ncbi.nlm.nih.gov/pubmed/34381664
http://dx.doi.org/10.1016/j.pmedr.2021.101448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334715/
https://www.ncbi.nlm.nih.gov/pubmed/34381664
http://dx.doi.org/10.1016/j.pmedr.2021.101448

Ejemplares similares